Stock Research: Hisamitsu Pharmaceutical

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Hisamitsu Pharmaceutical

TSE:4530 JP3784600003
67
  • Value
    78
  • Growth
    6
  • Safety
    Safety
    98
  • Combined
    74
  • Sentiment
    41
  • 360° View
    360° View
    67
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Hisamitsu Pharmaceutical Co Inc is a Japan-based company primarily engaged in the pharmaceutical business, including manufacturing, sales, and supply of pharmaceuticals and related products, and over-the-counter drug (OTC) operations. It also engages in urban cable television broadcasting, Internet connection services, non-life insurance agency, advertising agency, and packing material businesses. The company operates in Japan, the United States, Brazil, Vietnam, Indonesia, Europe, China, and Hong Kong. In the last fiscal year, the company had 2799 employees, a market cap of $2002 million, profits of $606 million, and revenue of $1036 million.

more
Index
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 18-Dec-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
78 42 56 59
Growth
6 67 65 33
Safety
Safety
98 86 98 100
Sentiment
41 76 34 90
360° View
360° View
67 92 77 93
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
16 12 20 24
Opinions Change
50 97 50 99
Pro Holdings
n/a 84 54 86
Market Pulse
73 61 65 65
Sentiment
41 76 34 90
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
78 42 56 59
Growth
6 67 65 33
Safety Safety
98 86 98 100
Combined
74 81 96 72
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
59 49 47 58
Price vs. Earnings (P/E)
50 37 45 56
Price vs. Book (P/B)
74 64 67 72
Dividend Yield
84 56 55 60
Value
78 42 56 59
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
16 34 41 64
Profit Growth
22 63 63 57
Capital Growth
26 59 49 42
Stock Returns
44 76 65 11
Growth
6 67 65 33
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
81 89 91 88
Refinancing
90 71 81 85
Liquidity
92 82 92 94
Safety Safety
98 86 98 100

Similar Stocks

Discover high‑ranked alternatives to Hisamitsu Pharmaceutical and broaden your portfolio horizons.

Japan Airlines

TSE:9201
Country: Japan
Industry: Airlines
Size: X-Large
Full Stock Analysis

Alfresa Holdings

TSE:2784
Country: Japan
Industry: Health Care Distributors
Size: Large
Full Stock Analysis

Starts

TSE:8850
Country: Japan
Industry: Real Estate: Diversified Operations
Size: Medium
Full Stock Analysis

Kyudenko

TSE:1959
Country: Japan
Industry: Construction & Engineering
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

This stock is a good value with safe financing, but has low growth and negative sentiment. It is a good option for a cautious value investor looking for stability but who can tolerate low momentum and skeptical professional opinion.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: